Family · Pharmaceutical analytical standards
Mesalazine
5-aminosalicylic acid, an anti-inflammatory that acts directly on the lining of the gut: in 1977 it was recognised as the active part of sulfasalazine and it is now a mainstay of ulcerative colitis treatment. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?Sulfasalazine, its parent drug, was developed between the late 1930s and the early 1940s by Nanna Svartz, Sweden's first female professor of medicine, with rheumatoid arthritis in mind.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
